Quizartinib Low Dose Clinical Trials

1 actively recruiting trial across 1 location

Also known as: VANFLYTA®

Filter by location:

Baltimore, Maryland1 trial

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

John Hopkins School of Medicine

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.